AGXT and primary hyperoxaluria type 1: Additionally, our previous studies demonstrated that AAV‐delivered base editors could rectify Agxt mutations in PH1 rats with therapeutic effects, but the limited correction efficiency in vivo failed to achieve a phenotypic cure of PH1.24